Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med. 2002, 346 (13): 995-1008. 10.1056/NEJMra010501.
Article
PubMed
Google Scholar
McMillan R, Nugent D: The effect of antiplatelet autoantibodies on megakaryocytopoiesis. Int J Hematol. 2005, 81 (2): 94-99. 10.1532/IJH97.04168.
Article
CAS
PubMed
Google Scholar
McMillan R, Bussel JB, George JN, Lalla D, Nichol JL: Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol. 2008, 83 (2): 150-154. 10.1002/ajh.20992.
Article
PubMed
Google Scholar
Feudjo-Tepie MA, Robinson NJ, Bennett D: Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. J Thromb Haemost. 2008, 6 (4): 711-712. 10.1111/j.1538-7836.2008.02911.x. author reply 713
Article
CAS
PubMed
Google Scholar
Segal JB, Powe NR: Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006, 4 (11): 2377-2383. 10.1111/j.1538-7836.2006.02147.x.
Article
CAS
PubMed
Google Scholar
George JN: Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006, 4 (8): 1664-1672. 10.1111/j.1538-7836.2006.02013.x.
Article
CAS
PubMed
Google Scholar
Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B: The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000, 160 (11): 1630-1638. 10.1001/archinte.160.11.1630.
Article
CAS
PubMed
Google Scholar
Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A: Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001, 97 (9): 2549-2554. 10.1182/blood.V97.9.2549.
Article
CAS
PubMed
Google Scholar
British Committee for Standards in Haematology General Haematology Task Force: Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003, 120 (4): 574-596.
Article
Google Scholar
Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F, Cheze S, Legouffe E, Hulin C, Grange MJ, et al: Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002, 359 (9300): 23-29. 10.1016/S0140-6736(02)07275-6.
Article
CAS
PubMed
Google Scholar
Cines DB, Bussel JB: How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005, 106 (7): 2244-2251. 10.1182/blood-2004-12-4598.
Article
CAS
PubMed
Google Scholar
Kojouri K, Vesely SK, Terrell DR, George JN: Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004, 104 (9): 2623-2634. 10.1182/blood-2004-03-1168.
Article
CAS
PubMed
Google Scholar
Godeau B, Porcher R, Fain O, et al: Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008, 112: 999-1004. 10.1182/blood-2008-01-131029.
Article
CAS
PubMed
Google Scholar
Stasi R, Pagano A, Stipa E, Amadori S: Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood. 2001, 98 (4): 952-957. 10.1182/blood.V98.4.952.
Article
CAS
PubMed
Google Scholar
Panzer S: New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review. Vox Sang. 2008, 94 (1): 1-5.
CAS
PubMed
Google Scholar
Aledort LM, Salama A, Kovaleva L, Robak T, Newland AC, Nugent DJ, Brenner B, Zenker O: Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura. Hematology. 2007, 12 (4): 289-295. 10.1080/10245330701383908.
Article
CAS
PubMed
Google Scholar
Orbach H, Katz U, Sherer Y, Shoenfeld Y: Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol. 2005, 29 (3): 173-184. 10.1385/CRIAI:29:3:173.
Article
CAS
PubMed
Google Scholar
Kumar S, Diehn FE, Gertz MA, Tefferi A: Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol. 2002, 81 (6): 312-319. 10.1007/s00277-002-0461-8.
Article
CAS
PubMed
Google Scholar
Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG: Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007, 146 (1): 25-33.
Article
PubMed
Google Scholar
Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL: A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007, 5: 11-10.1186/1477-7525-5-11.
Article
PubMed
PubMed Central
Google Scholar
Sarpatwari A, Watson S, Anderson H, Provan D, Newland A: Health-related lifestyle among adult and pediatric patients with idiopathic thrombocytopenic purpura in the United Kingdom. 50th American Society of Hematology Annual Meeting. 2008, 112 (11): 3435-
Google Scholar
Fadem SZ, Walker DR, Abbott G, Friedman AL, Goldman R, Sexton S, Buettner K, Robinson K, Peters TG: Satisfaction with renal replacement therapy and education: the american association of kidney patients survey. Clin J Am Soc Nephrol. 2011, 6 (3): 605-612. 10.2215/CJN.06970810.
Article
PubMed
PubMed Central
Google Scholar
Brown TM, Pashos CL, Joshi AV, Lee WC: The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics. Haemophilia. 2011, 17 (3): 476-482. 10.1111/j.1365-2516.2010.02401.x.
Article
CAS
PubMed
Google Scholar
Poulin Y, Papp KA, Wasel NR, Andrew R, Fraquelli E, Bernstein G, Chan D: A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis. Int J Dermatol. 2010, 49 (12): 1368-1375. 10.1111/j.1365-4632.2010.04660.x.
Article
PubMed
Google Scholar
Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS: Correlates of bother following treatment for clinically localized prostate cancer. J Urol. 2010, 184 (4): 1309-1315. 10.1016/j.juro.2010.06.012.
Article
PubMed
Google Scholar
Likert R: A technique for the measurement of attitudes. Arch Psych. 1932, 140: 1-55.
Google Scholar
Fries AF: Survey of non-traditional treatments of ITP preliminary results. The Platelet News. 2002, 3 (3): 4-5.
Google Scholar
Matzdorff A, Arnold G: Treatment of chronic immune thrombocytopenic purpura: the patients' perspective. Eur J Haematol. 2007, 78 (5): 381-388. 10.1111/j.1600-0609.2007.00829.x.
Article
PubMed
Google Scholar
Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007, 357 (22): 2237-2247. 10.1056/NEJMoa073275.
Article
CAS
PubMed
Google Scholar